Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga–Prostate-Specific Membrane Antigen PET/CT. (June 2018)

• Record Type: Journal Article
• Authors: Arora, Saurabh; Damle, Nishikant Avinash; Aggarwal, Sameer; Passah, Averilicia; Behera, Abhishek; Arora, Geetanjali; Bal, Chandrasekhar; Tripathi, Madhavi
• Is Part Of: Clinical nuclear medicine. Volume 43:Number 6(2018)
• Publication Date: 2018-06
• Subjects: adrenocortical carcinoma -- metastasis -- PET/CT -- PSMA; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000002064
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: We present here a case of metastatic adrenocortical carcinoma with bilateral lung nodules. The patient had been treated with mitotane therapy initially and then was later referred for chemotherapy. There was progression of disease noted on the 18 F-FDG PET/CT. 68 Ga prostate-specific membrane antigen (PSMA) PET/CT was planned to explore the possibility of future treatment with 177 Lu-DKFZ-PSMA-617. It revealed peripheral increased uptake of 68 Ga-HBED-CC-PSMA equal to liver uptake.